Home
About
FAQ
History (12)
Re: TP53INP1 as new therapeutic target in castration-resistant prostate cancer.
beta-Crystallins
Doshi, Renu
Receptor, Fibroblast Growth Factor, Type 4
Systolic Blood Pressure Intervention Trial: Alzheimer's, Seniors and Kidneys (SPRINT-ASK)
See All 12 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Systolic Blood Pressure Intervention Trial: Alzheimer's, Seniors and Kidneys (SPRINT-ASK)
Biography
contributor
Principal Investigator
Time
start date
2017-09-01
end date
2018-05-31
